|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 45.00 | ACUITE BB- | Downgraded | Issuer not co-operating* | - |
Total Outstanding | 45.00 | - | - |
Rating Rationale |
Acuité has downgraded the long-term rating to 'ACUITE BB-' (read as ACUITE double B minus) from 'ACUITE BB' (read as ACUITE double B) on the Rs. 45.00 crore bank facilities of Pasaydan Charitable Foundation on account of information risk. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
About the Company |
Pasaydan Charitable Foundation is a Mumbai based non-profit company incorporated in 2018. It is established to provide affordable healthcare facilities in and around Ghatkopar from a leased premises situated near Jagruti Nagar Metro Station. It commenced its operations in December 2018. Initially, the company was only operating an Out Patient Department (OPD). In December 2019, it got the necessary approvals to commence other facilities and is currently carrying out expansion work and likely to be completed by March 31, 2021. Post completion of the expansion, the hospital will have 125 beds, a pathology lab, radiology and sonography facility, a dialysis center and two operation theatres. The company currently has leased the building for its operations however, it plans to buy the building. The total project cost is expected to be Rs. 54.02 crore with Rs. 40.41 crore funded by debt and rest through promoter's contributions. Pasaydan Charitable Foundation is promoted by Dr. Sneh shashank Yadav and his wife Dr. Geetanjali Yadav. |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
Limitation regarding information availability: |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavored to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit ratingis based. |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 20 (Provisional) | FY 19 (Actual) |
Operating Income | Rs. Cr. | 0.66 | 0.20 |
PAT | Rs. Cr. | (1.11) | (0.18) |
PAT Margin | (%) | (168.91) | (91.24) |
Total Debt/Tangible Net Worth | Times | (2.35) | 0.00 |
PBDIT/Interest | Times | (5.58) | 0.00 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Service Sector: https://www.acuite.in/view-rating-criteria-50.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on Complexity Levels of the Rated Instrument |
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in. |
|
|
|
|||||||||||||||||||||||||||
|
Contacts |
|
|
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |